MTBC Offers Free e-Prescribing Solution to Physicians Affected by New Law  

SOMERSET, N.J., March 31, 2016 -- MTBC (NASDAQ:MTBC), a leading provider of proprietary, healthcare information technology solutions today announced it’s providing its leading e-prescribing solution free of charge for a limited period of time to physicians who have yet to implement an e-prescribing solution in the wake of New York’s new e-prescribing mandate.

“As of this week, New York’s I-STOP law took effect for all New York physicians and pharmacists,” said Amritpal Deol, MTBC General Counsel. She added, “I-STOP, which marks the beginning of a national trend, requires that all prescriptions be issued electronically, thereby rendering the paper prescription pad a relic of a bygone era.”

As part of MTBC’s I-STOP promotion, New York physicians who signup for MTBC’s e-prescribing by May 1, 2016, are entitled to use MTBC eRx free of charge for one year.  This promotional offer is limited to 5 physicians per practice and only available to the first 500 physicians who contact MTBC.

MTBC eRx, MTBC’s proprietary electronic prescribing solution, is fully integrated with PracticePro^TM, which includes a certified web-based EHR, practice management and revenue cycle management system. MTBC’s proprietary e-prescribing solution is available as an app, MTBC iRx, for Apple and Android users and an app for Apple Watch.

All of MTBC e-prescribe solutions are Surescripts® White Coat certified and facilitate controlled substances electronic prescribing through integration with EPCS Gold 2.0 by DrFirst®.

To learn more about MTBC, please visit www.mtbc.com. 

About Medical Transcription Billing, Corp.
Medical Transcription Billing, Corp. is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. Our integrated Software-as-a-Service (or SaaS) platform helps our customers increase revenues, streamline workflows and make better business and clinical decisions, while reducing administrative burdens and operating costs. MTBC's common stock trades on the NASDAQ Capital Market under the ticker symbol "MTBC," and its Series A Preferred Stock trades on the NASDAQ Capital Market under the ticker symbol "MTBCP."

For additional information, please visit our website at www.mtbc.com.

Press Contact:
Amritpal Deol, 
Vice President and General Counsel
MTBC
[email protected]
(732) 873-5133 x 141